ZebiAI

Waltham, United States Founded: 2019 • Age: 7 yrs Acquired By Relay Therapeutics
AI solutions for small molecule drug discovery are provided.
Request Access

About ZebiAI

ZebiAI is a company based in Waltham (United States) founded in 2019 by Richard Wagner was acquired by Relay Therapeutics in April 2021.. ZebiAI operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.

  • Headquarter Waltham, United States
  • Founders Richard Wagner
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Relay Therapeutics

    (Apr 16, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of ZebiAI
Headcount 10-50
Employee Profiles 5
Board Members and Advisors 2
Employee Profiles
People
Rafa Gomez-Bombarelli
Chief Learning Officer
People
Ed Koval
Chief Business Officer
People
Brant Binder
President
People
John Cuozzo
SVP and Head of Drug Discovery

Unlock access to complete

Board Members and Advisors
people
Christelle Huguet
Chair, Scientific Advisory Board
people
Richard Wagner
Founder and Director

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of ZebiAI

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ZebiAI

ZebiAI has secured backing from 1 investor. Prominent investors backing the company include Relay Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Drug discovery platform is developed to study protein motion.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ZebiAI

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ZebiAI

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Zebiai Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ZebiAI

ZebiAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
An agentic AI platform is developed for biomedical research insights.
domain founded_year HQ Location
AI-powered drug discovery platform for various diseases
domain founded_year HQ Location
AI-based technology is used for recombinant protein production in therapeutics.
domain founded_year HQ Location
Antibody therapies are developed through machine learning and synthetic biology.
domain founded_year HQ Location
AI-based platform for cancer diagnostics and precision medicine is utilized.
domain founded_year HQ Location
AI platform used for extracting antibody data from scientific papers.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Zebiai

Frequently Asked Questions about ZebiAI

When was ZebiAI founded?

ZebiAI was founded in 2019.

Where is ZebiAI located?

ZebiAI is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.

What does ZebiAI do?

ZebiAI was founded in 2019 and is based in Waltham, United States. Machine learning algorithms are utilized by the company to identify potential clinical candidate molecules and predict their pharmaceutical properties within the small molecule drug discovery sector. Operations focus on AI-driven tools for biotech and pharmaceutical applications. Partnerships are maintained with entities including X-Chem, Google, and SGC to support these efforts.

Who are the top competitors of ZebiAI?

ZebiAI's top competitors include Owkin, Formation Bio and XtalPi.

Who are ZebiAI's investors?

ZebiAI has 1 investor. Key investors include Relay Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available